肝血管平滑肌脂肪瘤(HAML)是一种罕见的脂肪组织肿瘤,平滑肌细胞,和血管。另一方面,炎症性乳腺癌(IBC)是一种罕见且严重的乳腺癌,进展迅速,表现为乳房炎症。HAML和IBC在同一患者中共存是非常不寻常的。在本研究中,我们描述了一例63岁的也门女性患者,该患者被诊断为局部晚期左乳腺癌,并出现左乳房和腋窝疼痛.用于分期的计算机断层扫描(CT)扫描显示偶然的大肝脏肿块,最终被发现是HAML。该患者在完成新辅助治疗后接受了改良的根治性乳房切除术,随后对该病变进行了保留实质的肝切除术;随访至今。由于重叠的临床和放射学特征,在IBC存在下诊断HAML可能会带来挑战。合并HAML和IBC的患者的治疗决策需要多学科方法;手术切除,栓塞,靶向治疗,和全身化疗可以根据疾病的程度和个体患者的因素考虑。最后,还对相关文献进行了简要回顾。
Hepatic angiomyolipoma (HAML) is a rare tumor comprising adipose tissue, smooth muscle cells, and blood vessels. On the other hand, inflammatory breast cancer (IBC) is a rare and severe form of breast cancer that progresses quickly and presents as breast inflammation. It is incredibly unusual for HAML and IBC to coexist in the same patient. In the present study, we describe a case of a 63-year-old Yemeni female patient diagnosed with locally advanced left breast cancer presented with pain at the left breast and axilla. A computed tomography (CT) scan for staging showed an incidental large hepatic mass, which was eventually discovered to be HAML. The patient underwent a modified radical mastectomy after completing her neoadjuvant treatment and later underwent parenchyma-sparing liver resection of that lesion; follow-up has continued till now. The diagnosis of HAML in the presence of IBC can pose challenges due to overlapping clinical and radiological features. Treatment decisions for patients with coexisting HAML and IBC require a multidisciplinary approach; surgical resection, embolization, targeted therapies, and systemic chemotherapy may be considered based on the extent of the disease and individual patient factors. Lastly, a brief review of the related literature was also carried out.